Annual Cash & Cash Equivalents
$24.13 M
+$18.05 M+297.38%
December 31, 2024
Summary
- As of March 13, 2025, ITRM annual cash & cash equivalents is $24.13 million, with the most recent change of +$18.05 million (+297.38%) on December 31, 2024.
- During the last 3 years, ITRM annual cash & cash equivalents has fallen by -$3.32 million (-12.10%).
- ITRM annual cash & cash equivalents is now -45.85% below its all-time high of $44.55 million, reached on December 31, 2018.
Performance
ITRM Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$24.13 M
+$10.72 M+79.96%
December 1, 2024
Summary
- As of March 13, 2025, ITRM quarterly cash and cash equivalents is $24.13 million, with the most recent change of +$10.72 million (+79.96%) on December 1, 2024.
- Over the past year, ITRM quarterly cash and cash equivalents has increased by +$10.72 million (+79.96%).
- ITRM quarterly cash and cash equivalents is now -71.58% below its all-time high of $84.90 million, reached on June 30, 2018.
Performance
ITRM Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
ITRM Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +297.4% | +80.0% |
| 3 y3 years | -12.1% | +80.0% |
| 5 y5 years | +402.5% | +80.0% |
ITRM Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -12.1% | +297.4% | -23.1% | +400.9% |
| 5 y | 5-year | -12.1% | +402.5% | -63.8% | +402.5% |
| alltime | all time | -45.9% | +402.5% | -71.6% | +402.5% |
Iterum Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $24.13 M(+297.4%) | - |
| Dec 2024 | - | $24.13 M(+80.0%) |
| Sep 2024 | - | $13.41 M(+169.4%) |
| Jun 2024 | - | $4.98 M(-32.7%) |
| Mar 2024 | - | $7.39 M(+21.7%) |
| Dec 2023 | $6.07 M(-71.2%) | $6.07 M(+26.1%) |
| Sep 2023 | - | $4.82 M(-64.9%) |
| Jun 2023 | - | $13.73 M(-18.4%) |
| Mar 2023 | - | $16.83 M(-20.2%) |
| Dec 2022 | $21.09 M(-23.2%) | $21.09 M(+2.9%) |
| Sep 2022 | - | $20.49 M(+122.5%) |
| Jun 2022 | - | $9.21 M(-70.6%) |
| Mar 2022 | - | $31.36 M(+14.3%) |
| Dec 2021 | $27.45 M | $27.45 M(-23.7%) |
| Sep 2021 | - | $35.98 M(-1.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2021 | - | $36.57 M(-45.1%) |
| Mar 2021 | - | $66.64 M(+359.3%) |
| Dec 2020 | $14.51 M(+202.2%) | $14.51 M(+69.3%) |
| Sep 2020 | - | $8.57 M(-30.0%) |
| Jun 2020 | - | $12.25 M(-47.3%) |
| Mar 2020 | - | $23.26 M(+384.4%) |
| Dec 2019 | $4.80 M(-89.2%) | $4.80 M(-83.4%) |
| Sep 2019 | - | $28.88 M(-43.6%) |
| Jun 2019 | - | $51.24 M(-20.7%) |
| Mar 2019 | - | $64.60 M(+45.0%) |
| Dec 2018 | $44.55 M(+425.1%) | $44.55 M(+12.5%) |
| Sep 2018 | - | $39.60 M(-53.4%) |
| Jun 2018 | - | $84.90 M(+121.9%) |
| Mar 2018 | - | $38.26 M(+350.9%) |
| Dec 2017 | $8.48 M(-65.8%) | $8.48 M |
| Dec 2016 | $24.81 M | - |
FAQ
- What is Iterum Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Iterum Therapeutics?
- What is Iterum Therapeutics annual cash & cash equivalents year-on-year change?
- What is Iterum Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Iterum Therapeutics?
- What is Iterum Therapeutics quarterly cash and cash equivalents year-on-year change?
What is Iterum Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of ITRM is $24.13 M
What is the all time high annual cash & cash equivalents for Iterum Therapeutics?
Iterum Therapeutics all-time high annual cash & cash equivalents is $44.55 M
What is Iterum Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, ITRM annual cash & cash equivalents has changed by +$18.05 M (+297.38%)
What is Iterum Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of ITRM is $24.13 M
What is the all time high quarterly cash and cash equivalents for Iterum Therapeutics?
Iterum Therapeutics all-time high quarterly cash and cash equivalents is $84.90 M
What is Iterum Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, ITRM quarterly cash and cash equivalents has changed by +$10.72 M (+79.96%)